Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Wuxi Pharmatech (Cayman) Inc facilities passed FDA general GMP inspection


Wednesday, 30 Apr 2014 08:00am EDT 

Wuxi Pharmatech (Cayman) Inc:Analytical and stability testing facilities, in Shanghai Waigaoqiao Free Trade Zone, passed an FDA general GMP inspection.This achievement brings regulatory advantages and potential expedited approval to clients who use these WuXi services for their NDA/ANDA filings and commercial analytical and stability testing.Clinical trial materials manufacturing for drug products (CTM), packaging and labeling facilities were also inspected and found to be in compliance. 

Company Quote

37.75
-0.07 -0.19%
30 Oct 2014